Variant report
Variant | nsv975187 |
---|---|
Chromosome Location | chr11:56785384-56791087 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:14)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:14 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr11:56785783-56786060 | A549 | lung: | n/a | n/a |
2 | CEBPB | chr11:56785764-56786096 | IMR90 | lung: | n/a | n/a |
3 | FOS | chr11:56790610-56791024 | MCF10A-Er-Src | breast: | n/a | n/a |
4 | FOS | chr11:56790622-56790963 | MCF10A-Er-Src | breast: | n/a | n/a |
5 | FOS | chr11:56790643-56790940 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | POLR2A | chr11:56785795-56785886 | GM12878 | blood: | n/a | n/a |
7 | POLR2A | chr11:56787104-56787286 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | POLR2A | chr11:56790740-56791991 | MCF10A-Er-Src | breast: | n/a | n/a |
9 | STAT3 | chr11:56790642-56791035 | MCF10A-Er-Src | breast: | n/a | n/a |
10 | STAT3 | chr11:56789794-56789970 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | STAT3 | chr11:56788519-56788780 | MCF10A-Er-Src | breast: | n/a | n/a |
12 | STAT3 | chr11:56790705-56790870 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | STAT3 | chr11:56790402-56791152 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | STAT3 | chr11:56790701-56791035 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
OR5AK1P | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs576097554 | chr11:56788601-56788602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs145135555 | chr11:56788641-56788642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190837974 | chr11:56788704-56788705 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs532417946 | chr11:56788720-56788721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540880305 | chr11:56788721-56788722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181027392 | chr11:56788824-56788825 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs559714867 | chr11:56788847-56788848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554183455 | chr11:56788858-56788859 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs377215448 | chr11:56788901-56788902 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs76490175 | chr11:56788941-56788942 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs577338205 | chr11:56788981-56788982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs184992490 | chr11:56789015-56789016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs138919922 | chr11:56789067-56789068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs142255920 | chr11:56789071-56789072 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546395023 | chr11:56789099-56789100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs369488307 | chr11:56789139-56789140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs567713777 | chr11:56789220-56789221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs35374403 | chr11:56789289-56789290 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs56892375 | chr11:56789365-56789366 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs35050414 | chr11:56789612-56789613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183205485 | chr11:56789636-56789637 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs563107264 | chr11:56789669-56789670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs531422851 | chr11:56789671-56789672 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs544122356 | chr11:56789681-56789682 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs3017317 | chr11:56789707-56789708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs541276259 | chr11:56789736-56789737 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs559678490 | chr11:56789764-56789765 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs574796729 | chr11:56789789-56789790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs187411967 | chr11:56789790-56789791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs191646574 | chr11:56789872-56789873 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs531798529 | chr11:56789895-56789896 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10896566 | chr11:56789911-56789912 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs565065211 | chr11:56789936-56789937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs527301270 | chr11:56789967-56789968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs12419826 | chr11:56789983-56789984 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs112419935 | chr11:56790014-56790015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs188132722 | chr11:56790034-56790035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs201491520 | chr11:56790053-56790054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548140062 | chr11:56790092-56790093 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs570678694 | chr11:56790127-56790128 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs12418588 | chr11:56790180-56790181 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs117734071 | chr11:56790186-56790187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192663888 | chr11:56790194-56790195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs10466677 | chr11:56790205-56790206 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs183900494 | chr11:56790207-56790208 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs186793903 | chr11:56790210-56790211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs373891413 | chr11:56790215-56790216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs547090477 | chr11:56790216-56790217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs563636880 | chr11:56790239-56790240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs576338083 | chr11:56790244-56790245 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Breast cancer | 17142309 | CNVD |
Autism | 22495309 | CNVD |
Autism | 20808228 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:56788600-56789000 | Enhancers | HUES48 Cell Line | embryonic stem cell |
2 | chr11:56788800-56789400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
3 | chr11:56789000-56789400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr11:56789600-56790400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
5 | chr11:56790400-56791000 | Weak transcription | Foreskin Melanocyte Primary Cells skin03 | Skin |
6 | chr11:56791000-56791200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |